Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Matthew Fuller
Introduction: Matthew Fuller is a notable inventor based in Social Circle, GA (US). He has made significant strides in the field of biotechnology, particularly in the development of novel therapeutic methods. His work focuses on the interaction between peptides and ABC transporters, which are crucial for various biological processes.
Latest Patents: Matthew Fuller holds a patent for the invention titled "ABC transporter ligand GATX1." This patent describes compositions and methods utilizing a scorpion venom peptide that acts as a ligand for ABC transporters. The peptide is characterized by having at least 80% sequence identity to SEQ ID NO: 1. It is believed to have a molecular mass of about 3.7 kDa and specifically interacts with the cystic fibrosis transmembrane conductance regulator. The patent also outlines methods for treating disorders related to aberrant ABC transporter activity.
Career Highlights: Matthew Fuller is associated with the Georgia Tech Research Corporation, where he continues to advance his research and innovation in the field. His work has the potential to impact the treatment of various disorders, showcasing his commitment to improving healthcare through scientific discovery.
Collaborations: Matthew has collaborated with esteemed colleagues such as Nael McCarty and Julia M Kubanek. These partnerships enhance the research environment and contribute to the development of innovative solutions in biotechnology.
Conclusion: Matthew Fuller exemplifies the spirit of innovation in the field of biotechnology through his groundbreaking work and patent contributions. His research not only advances scientific knowledge but also holds promise for future therapeutic applications.